Sky Medical Technology, which develops bioelectronic devices to prevent a range of life-threatening blood clot conditions, will now be able to market its product in the USA. The clearance also follows similar backing for Geko - an external device for blood clots.
Chief executive Bernard Ross said: "Our proven model of partnering with healthcare clinicians both at home and globally has been a key tenet to growing our export activity, and has ensured success in multiple markets and areas of clinical practice. "This rapid growth is a result of collaboration with early adopters in the UK, which has generated crucial proven clinical and health economic data, which is now translating internationally. New care pathways are in development and we plan to submit further FDA applications to expand our claims.
To read more, please click here.